Trial intelligence / Profile preview

Enterovirus 71 Vaccine (Vero Cell), Inactivated Batch Consistency and Safety Study in Children

CTR20191004Phase 4Completed

Sponsor
Wuhan Institute of Biological Products
Start
May 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Inactivated Enterovirus Type 71 Vaccine (Vero Cell), sponsored by Wuhan Institute of Biological Products. Started May 2019; status: completed.

02

Drugs

Inactivated Enterovirus Type 71 Vaccine (Vero Cell)

Beyond the preview

Go deeper on CTR20191004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20191004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call